Heliosonix (Houston-based) is an imaging technology company for preclinical and clinical applications. Our optoacoustic imaging technology has been validated with a number of customers globally, including leading US academic and medical centers. We generate revenue with our animal research product: We have a number of deliveries in 2020 (revenue is booked) and a multi-million dollar sales funnel. Our clinical products include cancer and stroke diagnostics and image-guided interventions with TAM $10B+: We have multiple shots on goal to launch a $1B+ product. Our team consists of MedTech veterans of Medtronic and J&J, and our technical founder is recognized as “the father of biomedical optoacoustic imaging.”
